Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02501837Phase 1Completed
Phase 1, randomised, double-blind trial of oxytocin nasal spray, sponsored by University Hospital Bonn. Primary endpoints: Neural response to photographs of the partner at 1 hour and Neural response during the regulation of food craving at 1 hour. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02501837.